What is it about?
At present, timely and accurate diagnosis and effective treatment of Epstein-Barr Virus (EBV) infection-associated fever remain a difficult challenge. EBV encodes 44 mature microRNAs (miRNAs) that inhibit viral lysis, adjust inflammatory response, regulate cellular apoptosis, promote tumor genesis and metastasis, and regulate tumor cell metabolism. Herein, we have collected the specific expression data of EBV-miRNAs in EBV-related fevers [including infectious mononucleosis (IM), EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH), chronic active EBV infection (CAEBV), and EBV-related tumors] and proposed the potential value of EBV-miRNAs as biomarkers to assist in the identification, diagnosis, and prognosis of EBV-related fever, as well as therapeutic targets for drug development.
Featured Image
Photo by Matteo Fusco on Unsplash
Read the Original
This page is a summary of: EBV-microRNAs as Potential Biomarkers in EBV-related Fever:
A Narrative Review, Current Molecular Medicine, January 2024, Bentham Science Publishers,
DOI: 10.2174/1566524023666221118122005.
You can read the full text:
Contributors
The following have contributed to this page
